GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Payments of Debt

IPDQF (Impedimed) Payments of Debt : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Payments of Debt?

Impedimed's Payments of Debt for the six months ended in Jun. 2024 was $0.00 Mil.

Impedimed's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.


Impedimed Payments of Debt Historical Data

The historical data trend for Impedimed's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Payments of Debt Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Impedimed Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Impedimed Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed Payments of Debt Related Terms

Thank you for viewing the detailed overview of Impedimed's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q2 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q1 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Investor Conference Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 ImpediMed Ltd Business Results Call Transcript

By GuruFocus Research 02-14-2024